Created in 2011 (Switzerland), IXAPANA own 2951 sister brands and 17477 competing brands. IXAPANA is owned by NOVARTIS N, listed on the stock exchange of Zurich The ISIN, the company's International Securities Identification Number, is CH0012005267. The sector of IXAPANA is Drug Manufacturers.
Investment simulator :
Portfolio valuation
NOVARTIS N
(IXAPANA)
over 5 years*
CHF 101.84